WD patients with neurological phenotype had higher serum GFAP concentrations than hepatic and controls (143.8 pg/mL vs. 107.5 p/mL vs. 86.8 pg/mL; p < 0.01), without statistically important differences between hepatic WD and HS. Here, GFAP is linked to Wilson disease.